Investigational Site Number 4280003

Sigulda LV-2150

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Diseases, Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early